The toxicity and efficacy of Nordic-FLOX regimen as adjuvant treatment of stage III colon cancer

Demir L., Somali I., Tarhan M. O., Erten C., ELLİDOKUZ H., Can A., ...Daha Fazla

JOURNAL OF BUON, cilt.16, sa.4, ss.682-688, 2011 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 16 Sayı: 4
  • Basım Tarihi: 2011
  • Dergi Adı: JOURNAL OF BUON
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.682-688
  • Anahtar Kelimeler: adjuvant treatment, colon cancer, efficacy, Nordic-FLOX regimen, toxicity, OXALIPLATIN-RELATED NEUROTOXICITY, METASTATIC COLORECTAL-CANCER, 1ST-LINE TREATMENT, RANDOMIZED-TRIAL, FOLINIC ACID, PHASE-III, FLUOROURACIL, LEUCOVORIN, LEVAMISOLE, CHEMOTHERAPY
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Purpose: To evaluate the toxicity and efficacy of oxaliplatin combined with the Nordic regimen of bolus 5-fluorouracil (5-FU) and leucovorin (LT) (Nordic-FLOX) as adjuvant treatment in stage III colon cancer patients.